Medical Design Technology

News

Subscribe to MDT Magazine News

Dr. Nie Wentao's New Method of Diabetic Nutrition Interventions

July 14, 2010 9:45 am | by Bio-Medicine.Org | Comments

YINCHUAN, China , July 14 /PRNewswire-Asia/ -- Recently, Xinhua Website reported about Dr. Nie Wentao's nutrition intervention technology for type 1 diabetes mellitus. Dr. Nie Wentao's diabetic treatment technology is becoming a mainstream technology for diabetes treatment, so it aroused...

TOPICS:

Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation

July 14, 2010 9:45 am | by Bio-Medicine.Org | Comments

SEATTLE and TULSA, Okla. , July 14 /- Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitestâ„¢ and Tamoxitestâ„¢. These tests and the GeneMedRx medication management...

TOPICS:

Renhuang Showcases its All Natural Products at 45th China National New and Special Drugs Fair

July 14, 2010 9:43 am | by Bio-Medicine.Org | Comments

HARBIN, China , July 14 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that...

TOPICS:
Advertisement

MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015

July 14, 2010 9:43 am | by Bio-Medicine.Org | Comments

DALLAS , July 14, 2010 /- According to a new market research report, 'Patient Monitoring Devices - Emerging Markets BRIC ( Brazil , Russia , India and China ) 2010-2015, published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the BRIC patient monitoring market is expected to...

TOPICS:

Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration

July 14, 2010 9:43 am | by Bio-Medicine.Org | Comments

LONDON , July 14 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") is pleased to announce a one-year extension of its ongoing research and development collaboration with AstraZeneca.  Under the terms of the agreement, which has progressed well since being signed in...

TOPICS:

Sector Snap: SEC inquiry sacks home health stocks

July 14, 2010 8:45 am | by The Associated Press | Comments

Shares of home health providers sank Wednesday as an investigation into the industry's Medicare reimbursement practices expanded.After the markets closed on Tuesday, LHC Group Inc. and Gentiva Health Services Inc. said they are being investigated by the Securities and Exchange Commission. LHC...

Half of swine flu deaths were in previously healthy people, research finds

July 14, 2010 6:48 am | by EurekAlert | Comments

(University of Liverpool) Over half of UK swine flu hospital admissions and inpatient deaths occurred in people with no underlying health problems or obvious risk factors, research at the University of Liverpool has found.

TOPICS:

Researcher targets gene regulators on link between arsenic, cancer

July 14, 2010 6:48 am | by EurekAlert | Comments

(Michigan State University) To determine how arsenic increases the risk of lung cancer and to identify potential treatments, a Michigan State University researcher will use $1.7 million in federal funding during the next five years to examine why certain genes disrupt cells,...

TOPICS:
Advertisement

Federal Register: Town Hall Discussion With the Director of the Center for Devices and Radiological Health and Other Senior Center Management

July 14, 2010 5:32 am | by U.S. Food & Drug Administration | Comments

The purpose of this meeting is to present the CDRH Fiscal Year (FY) 2010 Priorities. In addition, FDA is interested in engaging in discussions about issues that are of importance to the medical device industry.

TOPICS:

Coumadin 1 mg Tablet Blister Packs: Recall(2)

July 14, 2010 5:31 am | by U.S. Food & Drug Administration | Comments

Some tablets may not meet specification for isopropanol, which could affect therapeutic levels of the active ingredient.

TOPICS:

Study shows universal surveillance for MRSA significantly decreased HAIs at PCMH

July 13, 2010 9:36 pm | by EurekAlert | Comments

(Manning Selvage & Lee) Pitt County Memorial Hospital today announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus decreased health care-associated infections related to devices. Infection rates decreased 68 percent...

TOPICS:

The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011

July 13, 2010 9:36 pm | by EurekAlert | Comments

(Samuel Waxman Cancer Research Foundation) The Samuel Waxman Cancer Research Foundation has awarded 13 collaborative grants and 3 individual grants, totaling $1.54 million to some of the best scientific minds in differentiation therapy.

TOPICS:

Diabetes Risk, on a Scale of 1 to 10

July 13, 2010 9:34 pm | by Massachusetts Institute of Technology | Comments

A new test is transforming the way some doctors diagnose and treat their patients.

TOPICS:

Arava (leflunomide): Boxed Warning - Risk of Severe Liver Injury

July 13, 2010 9:31 pm | by U.S. Food & Drug Administration | Comments

Warning highlights the risk of severe liver injury and how this risk may be reduced.

TOPICS:

SEC tells LHC Group to preserve Medicare documents

July 13, 2010 3:45 pm | by The Associated Press | Comments

Home care and hospice provider LHC Group Inc. said Tuesday the Securities and Exchange Commission ordered it to preserve all documents relating to its Medicare-reimbursement practices.The SEC indicated it plans to request the documents later, the company said. LHC said it intends to cooperate...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading